Prosolus Overview

  • Year Founded
  • 2009

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 12

Employees

  • Latest Deal Type
  • Debt - PPP

  • Financing Rounds
  • 4

Prosolus General Information

Description

Developer of transdermal drug delivery system intended for various therapeutic categories. The company specializes in transdermal patches, pain management, cardiovascular and neurologic care, enabling its customers to treat diseases in Florida.

Contact Information

Website
www.prosoluspharma.com
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Delivery
Parent Company
Canoa Importers
Primary Office
  • 6701 North West 7 Street
  • Miami, FL 33126
  • United States
+1 (305) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Prosolus Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Prosolus‘s full profile, request access.

Request a free trial

Prosolus Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of transdermal drug delivery system intended for various therapeutic categories. The company specializes in tr
Drug Delivery
Miami, FL
12 As of 2023
000000000 -

000000

derit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur
0000 00000000
Orlando, FL
0 As of 0000
00.000
00000000

0000 0

nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit
000000000000000
Oxnard, CA
00 As of 0000
0000
000000000 - 0000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Prosolus Competitors (11)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Nutriband Formerly Angel backed Orlando, FL 0 00.000 00000000
0000 0000000000000 Formerly VC-backed Oxnard, CA 00 0000 000000000 - 0000
000000000 Venture Capital-Backed Coventry, United Kingdom 00 000.00 0000000000 0 000.00
000000 000000 Formerly VC-backed Fremont, CA 00 00000 000000&0
0000000 Formerly PE-Backed Princeton, NJ 00000 00000 0&0
You’re viewing 5 of 11 competitors. Get the full list »

Prosolus Patents

  • 4

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 1

    Granted

  • 000

    Pending

  • 000

    Expiring in next 12 mo

Prosolus Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20170340577-A1 Transdermal drug delivery system Active 25-May-2016 0000000000
US-10010511-B2 Transdermal drug delivery system Inactive 25-May-2016 0000000000
US-10307380-B1 Composition and method for transdermal lidocaine delivery Inactive 04-Mar-2014 0000000000
US-9408802-B1 Seven day drug in adhesive transdermal delivery Active 22-Mar-2012 A61K9/7053

Prosolus Executive Team (4)

Name Title Board Seat Contact Info
Alejandro Moreno Chief Executive Officer & Chairman
Juan Mantelle Chief Operating Officer
Kevin Pate Vice President, Finance
You’re viewing 3 of 4 executive team members. Get the full list »

Prosolus Board Members (1)

Name Representing Role Since
000000000 000000 Prosolus Chief Executive Officer & Chairman 000 0000
To view Prosolus’s complete board members history, request access »

Prosolus Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial